Search

everythinglearnresearchcommunity

for

Search:↓

Melatonin improved mental health and metabolism in women with PCOS.

Abuse of anabolic steroids in Iraqi athletes leads to negative effects on hormones, liver and kidney function, blood sugar, and cholesterol levels.

Women with early onset androgenetic alopecia have worse lipid profiles.

Technological advancements and standardization are crucial for improving diagnostic accuracy and laboratory efficiency.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Men with Type 2 Diabetes have lower DHT levels, which may affect fertility and lipid profiles.

Lipocalin-2 levels are higher in women with PCOS and may indicate insulin resistance.

Adolescent females with PCOS have higher serum cystatin C levels, indicating potential metabolic and cardiovascular issues.

Testosterone therapy improves physical function, strength, and body composition in older men with low testosterone levels.

Dutasteride and finasteride do not significantly affect bone density, blood fats, or blood production, but slightly lower PSA levels and minimally impact sexual function in healthy young men.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Women with PCOS have similar levels of certain proteins compared to women without PCOS, and these proteins don't independently cause PCOS.

Lower vaspin levels in the blood may indicate a better response to fertility treatment in women with PCOS.

Men with male pattern baldness may have a higher risk of heart disease due to increased levels of a specific lipid in their blood.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

High chromogranin A levels are linked to obesity and inflammation in polycystic ovary syndrome.

Finasteride lowers cortisol and raises testosterone levels in rats.

Cardiac risk markers help assess heart risk in males with type 2 diabetes and low DHT.

Some men with early hair loss may have a male version of PCOS, affecting hormones and increasing health risks.

Women with PCOS have lower adiponectin hormone levels and are more likely to have insulin resistance.

NAFLD in PCOS patients is linked to early kidney problems.

Men with genetic hair loss are more likely to have abnormal blood lipid levels, especially if the hair loss is severe.

Men with a certain type of hair loss (AGA) have higher bad cholesterol and lower good cholesterol levels, making them more likely to get heart disease.

Non-obese women with hair loss have higher heart disease risk.

Minoxidil given intravenously caused small changes in diastolic blood pressure and increased heart rate at higher concentrations in patients with high blood pressure.

Male pattern baldness, especially the vertex type, could be an early sign of cardiovascular risk factors like high cholesterol and diabetes.

Many men with male pattern baldness have abnormal blood fat levels, which may raise their risk of heart disease.

Men with early hair loss may have higher insulin resistance and should be checked for related health issues.

Women with PCOS should be screened for heart disease risk and manage their health to prevent it.

People with alopecia are at higher risk for heart disease and have more heart-related risk factors.